SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-046990
Filing Date
2021-07-16
Accepted
2021-07-16 17:54:44
Documents
2
Period of Report
2021-07-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1600
2 POA DOCUMENT poa.txt EX-24.3_999353 3077
  Complete submission text file 0001209191-21-046990.txt   6100
Mailing Address BAUSCH HEALTH COMPANIES INC. 400 SOMERSET CORPORATE BLVD. BRIDGEWATER NJ 08807
Business Address
VON ESCHENBACH ANDREW C. (Reporting) CIK: 0001536529 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38914 | Film No.: 211096432

Mailing Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019 2126163700
GX Acquisition Corp. (Issuer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations